Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Rang in aandelen
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Aandeelprijs
$20.91
Marktkapitalisatie
$7.57B
Verandering (1 dag)
-8.26%
Verandering (1 jaar)
41.25%
Land
CN
Handel Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Categorie
Healthcare
EPS voor Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
EPS per June 2026 TTM: $0.43
Volgens de laatste financiële rapporten en de aandelenkoers van Asymchem Laboratories (Tianjin) Co., Ltd. is de huidige EPS van het bedrijf (TTM) $0.43. Eind 2024 had het bedrijf een EPS van $0.37, een daling ten opzichte van de EPS van 2023 die $0.88 bedroeg.
EPS-geschiedenis van Asymchem Laboratories (Tianjin) Co., Ltd. van 2011 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.43 | -3.49% |
| 2025 | $0.45 | 22.58% |
| 2024 | $0.37 | -58.33% |
| 2023 | $0.88 | -32.36% |
| 2022 | $1.31 | 163.84% |
| 2021 | $0.50 | 46.50% |
| 2020 | $0.34 | 36.19% |
| 2019 | $0.25 | 27.52% |
| 2018 | $0.19 | 17.35% |
| 2017 | $0.17 | 16.41% |
| 2016 | $0.14 | 51.86% |
| 2015 | $0.09 | 45.36% |
| 2014 | $0.06 | 30.51% |
| 2013 | $0.05 | 28.57% |
| 2012 | $0.04 | -6.55% |
| 2011 | $0.04 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $17.32 | 3,888.03% |
US
|
|
| $-7.98 | -1,937.44% |
US
|
|
| $-5.29 | -1,318.05% |
AU
|
|
| $13.70 | 3,054.52% |
BE
|
|
| $27.74 | 6,287.29% |
NL
|
